
Achieving glycemic control represents a key goal of type 2 diabetes (T2D) management. However, many individuals fail to achieve glycemic targets due to therapeutic inertia, and remaining in poor glycemic control can lead to increased risk of diabetes‐related complications over the short and long term. The present study aimed to evaluate the economic and clinical burden associated with poor glycemic control...
Like
Save
Share